Successful treatment of patients with hepatitis C in rural and remote Western Australia via telehealth

Journal of Telemedicine and Telecare

Volumn 19, Issue 2, 2013, Pages 101-106

  Nazareth, Saroja ^a   Kontorinis, Nickolas ^a   Muwanwella, Niroshan ^a   Hamilton, Alan ^a   Leembruggen, Nadine ^a   Cheng, Wendy Sc ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; AUSTRALIA; FEMALE; HEALTH; HEALTH CARE DELIVERY; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT SATISFACTION; QUESTIONNAIRE; RURAL POPULATION; TELECONSULTATION; VIDEOCONFERENCING; VIROLOGY; YOUNG ADULT;

ADULT; AGED; ANTIVIRAL AGENTS; DELIVERY OF HEALTH CARE; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; REMOTE CONSULTATION; RURAL HEALTH; RURAL POPULATION; VIDEOCONFERENCING; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 84880423303     PISSN: 1357633X     EISSN: 17581109     Source Type: Journal    
DOI: 10.1258/jtt.2012.120612     Document Type: Article

References (15)

1. Shah BB, Wong JB. The economics of hepatitis C virus. Clin Liver Dis 2006;10:717-34
2. Hepatitis Australia. Hepatitis C. 2010. See http://www.hepatitisaustralia.com/about-hepatitis/hepatitis-c (last checked 26 August 2012)
3. Department of Health, State of Western Australia. Hepatitis C virus model of care. See http://www.healthnetworks.health.wa.gov.au/modelsofcare/docs/HepatitisC_MOC.pdf (last checked 26 August 2012)
4. Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2011. See http://www.med.unsw.edu.au/NCHECRweb.nsf/resources/2011/$file/KIRBY_ASR2011.pdf (last checked 26 August 2012)
5. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-82
6. Hadziyannis SJ, Sette H, Morgan TR, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004;140:346-57
7. Torruellas C, Rossaro CC, Li C-S, Rossaro L. The use of telemedicine for the management of Hepatitis C and the California Telehealth Network. See http://www.intechopen.com/articles/show/title/the-use-of-telemedicine-forthe-management-of-hepatitis-cthe-california-telehealth-network (last checked 26 August 2012)
8. Rossaro L, Aoki C, Yuk J, Prosser C, Goforth J, Martinez F. The evaluation of patients with hepatitis C living in rural California via telemedicine. Telemed J E Health 2008;14:1127-29
9. Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment - extension for community healthcare outcomes (ECHO) project: disruptive innovation in speciality care. Hepatology 2010;52:1124-33
10. Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011;364:2199-07
11. Kobb R, Chumbler NR, Brennan DM, Rabinowitz T. Home telehealth: mainstreaming what we do well. Telemed J E Health 2008;14:977-81
12. Wallace M, Kong J, Nazareth S. Sustained virological response rates and predictors of treatment success at Royal Perth Hospital with pegylated interferon and ribavirin from 2001 to 2009. [Abstracts of Australian Gastroenterology Week 2010]. J Gastroenterol Hepatol 2010;25 (Suppl. 3):A1-A144
13. Adams L, Bulsara M, Rossi E, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005;51:1867-73
14. Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009;41:1100-04
15. López C, Valenzuela JI, Calderón JE, Velasco AF, Fajardo R. A telephone survey of patient satisfaction with realtime telemedicine in a rural community in Colombia. J Telemed Telecare 2011;17:83-7